Important Information for ModivCare Securities Purchasers: Deadline Approaching for Lead Plaintiff in Class Action Lawsuit
Rosen Law Firm, a renowned global investor rights law firm, is reminding purchasers of ModivCare Inc. (MODV) securities between November 3, 2022, and September 15, 2024 (the “Class Period”), of the significant lead plaintiff deadline in a class action lawsuit. This lawsuit alleges that ModivCare and certain of its top executives violated the Securities Exchange Act of 1934.
Background
ModivCare is a healthcare services company that provides in-home healthcare services and medical equipment to patients. The lawsuit alleges that the defendants made materially false and/or misleading statements and/or failed to disclose that:
- ModivCare’s business was not growing as reported.
- The company was experiencing significant patient attrition.
- ModivCare’s financial statements contained material misstatements and omissions.
- The defendants were aware of these issues but failed to disclose them to investors.
Compensation for Class Members
If you purchased ModivCare securities during the Class Period, you may be entitled to compensation without any out-of-pocket fees or costs through a contingency fee arrangement. This means that you can potentially recover your losses at no upfront cost to you. The lead plaintiff deadline is March 31, 2025.
Effect on Individual Investors
If you purchased ModivCare securities during the Class Period and have suffered losses, this lawsuit may provide you with the opportunity to recover those losses. It is essential to act quickly, as the lead plaintiff deadline is approaching. If you wish to learn more about the case or join the lawsuit, you can contact Rosen Law Firm by calling Phillip Kim, Esq. or Danielle Campoamor, Esq. at 866-767-3653 or via email at [email protected] or [email protected].
Effect on the World
The outcome of this lawsuit could potentially have a significant impact on the healthcare services industry as a whole, as it highlights the importance of accurate financial reporting and transparency. It could also serve as a reminder to investors to carefully evaluate the information provided by companies before making investment decisions. If the allegations are proven true, it could lead to increased regulatory scrutiny of the healthcare services industry and potentially result in stricter reporting requirements.
Conclusion
If you purchased ModivCare securities during the Class Period and have suffered losses, it is essential to act quickly and contact Rosen Law Firm to learn more about your options. The lead plaintiff deadline is approaching, and you may be entitled to compensation without any out-of-pocket fees or costs. This lawsuit could potentially have far-reaching implications for the healthcare services industry and serve as a reminder to investors to carefully evaluate the information provided by companies before making investment decisions.
